You are here

  • Home
  • Online First
  • There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

Article Text

Article menu

other Versions

Download PDFPDF
Commentary
There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

https://doi.org/10.1136/ijgc-2022-003348

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Contributors RS: Substantial contributions to the design of the manuscript, draft preparation, and final approval of the version to be published. LC: Substantial contributions to the conception of the manuscript, draft revision, and final approval of the version to be published. PH: Substantial contributions to the conception of the manuscript, draft revision, and final approval of the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.